SPRINGFIELD, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)(ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION, founded in 2008, is a small nonprofit in the Diseases & Disorders sector that reported $764K in total revenue in fiscal year 2024. Revenue surged 29% from the prior year, signaling strong growth momentum. The organization ran a surplus of $158K, a strong 21% operating margin.
TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP),APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENTS ABOUT THESE DISEASES.
AWARDED AND FUNDED RESEARCH GRANTS
SYMPOSIUM PARTICIPATION/SCHOLARSHIPS & SPONSORSHIP
PROVIDE EDUCATIONAL INFORMATION ON PMP AND RELATED CANCERS TO PATIENTS, FAMILIES OF PATIENTS AND ANY OTHER INTERESTED PARTIES THRU EDUCATIONAL SESSIONS, CONFERENCE EXHIBITS, PROGRAMS AND WEB
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $763,808 | $591,795 | +0.3% |
| Expenses | $605,626 | $238,992 | +1.5% |
| Net Income | $158,182 | $352,803 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES CARROLL | PRESIDENT | 15.00 |
Officer
Director
|
$0 | $0 | $0 |
| JUDITH CULBERTSON | TREAS/VP | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| DEBORAH SHELTON | SECY/EXEC DI | 30.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $763,808 | $605,626 | $2,218,027 | $158,182 |
| 2023 | $591,795 | $238,992 | $2,054,563 | $352,803 |
| 2022 | $467,148 | $228,028 | $1,699,668 | $239,120 |
| 2021 | $864,315 | $158,294 | $1,467,493 | $706,021 |
| 2020 | $391,196 | $265,909 | $756,554 | $125,287 |
| 2019 | $306,812 | $241,250 | $629,240 | $65,562 |
| 2018 | $383,708 | $203,894 | $563,678 | $179,814 |
Compare (ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION with other nonprofits in Pennsylvania and across the country.